Clear Crossing Biosciences
PrivateLast Round
Accelerator
May 1, 2024
Company Overview
Clear Crossing Biosciences is a biotechnology company that develops an endosomal release platform for targeted intracellular delivery of RNA therapeutics and therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clear Crossing Biosciences Comparables
Compare Clear Crossing Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Feldan Therapeutics | 82% | |
| Xelcis Bio, Inc. | 82% | |
| Sapreme Technologies BV | 81% | |
Clear Crossing Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 1, 2024 |
Key People
Founding team and executive leadership
Clear Crossing Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oregon Bioscience Incubator | Accelerator |
Clear Crossing Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Clear Crossing Biosciences's valuation, stock price, and market status.